https://www.selleckchem.com/products/ly333531.html
https://www.selleckchem.com/products/ly333531.html
Ocular adverse situations within PD-1 and PD-L1 inhibitors. BACKGROUND One of the most vulnerable times in a patient's encounter with a health care system is during transitions of care (TOC), defined by the Joint Commission as the movement of a patient from one health care provider or setting to another. The use of a clinical pharmacist as a member of the care transitions team has received focused attention and shown improved benefit. OBJECTIVE To determine the effect of a large-
Aimer
Commentaire
Partagez
